Exploring the Association of Genetic Determinants of SIRT1, MTHFR, and MIR146A Gene Polymorphism with the Ischemic Stroke Predisposition: A Case Control Study.
Abdullah Hamadi, Rashid Mir, Osama M Al-Amer, Mohammed Alasseiri, Mamdoh S Moawadh, Jameel Barnawi, Mohammad A Alanazi, Atif Abdulwahab A Oyouni, Abeer Al-Tuwaijri, Fawzyah Obeedallah Albaldi, Hassan A Madkhali
{"title":"Exploring the Association of Genetic Determinants of SIRT1, MTHFR, and MIR146A Gene Polymorphism with the Ischemic Stroke Predisposition: A Case Control Study.","authors":"Abdullah Hamadi, Rashid Mir, Osama M Al-Amer, Mohammed Alasseiri, Mamdoh S Moawadh, Jameel Barnawi, Mohammad A Alanazi, Atif Abdulwahab A Oyouni, Abeer Al-Tuwaijri, Fawzyah Obeedallah Albaldi, Hassan A Madkhali","doi":"10.1007/s10571-026-01688-9","DOIUrl":null,"url":null,"abstract":"<p><p>Stroke is a major cause of disability and the second greatest cause of death. Both acute and chronic strokes have few available treatment options. Nonetheless, the technique known as genome-wide association study (GWAS) is beginning to significantly influence our comprehension of the genetics of stroke. Therefore, the objective of the present study was to examine the associations between Sirtuin-1 (SIRT1), Methylenetetrahydrofolate reductase (MTHFR), and microRNA 146a (MIR146A) gene variations with ischemic stroke (IS) risk. The study included 200 participants: 100 with clinically confirmed IS and 100 healthy controls. Genotyping of SIRT1 (rs7069102), MTHFR (rs1801131), and MIR146A (rs2910164) was performed using the Amplification-Refractory Mutation System Polymerase Chain Reaction (ARMS-PCR). Blood biochemistry, including lipid profiles and glycemic markers, was determined using spectrophotometric enzymatic colorimetric assays. Statistical techniques employed included the Chi-square test, Fisher’s exact test, and multivariate logistic regression analysis to determine Odds Ratios (OR) and 95% Confidence Intervals (CI). In the codominant model, heterozygosity for MIR146A GC (OR = 1.97, P = 0.040), SIRT1 GC (OR = 1.84, P = 0.044), and MTHFR AC (OR = 2.55, P = 0.0019) was significantly associated with increased stroke susceptibility. In the dominant model, MIR146A (GC + CC), SIRT1 (GC + CC), and MTHFR (AC + CC) genotypes were strongly associated with increased risk (P < 0.05). In the recessive model, MIR146A CC and MTHFR CC genotypes were significantly associated with stroke risk, whereas the SIRT1 CC genotype did not reach statistical significance (P = 0.065). Allelic comparison revealed that the C alleles of MIR146A, SIRT1, and MTHFR were all strongly associated with stroke predisposition (P < 0.05). We conclude that there is a possible strong association between the SIRT1 rs7069102 C > G, MTHFR rs1801131 C > A and MIR146A rs2910164 C > G gene variants and ischemic stroke susceptibility. To the best of our knowledge, it is the first study to highlight the association between these genetic variations and the predisposition of stroke in our populations. Large-scale case–control studies in the future are required to confirm these results. These results, when confirmed, can be used in genetic testing for the screening and prognosis of stroke.</p>","PeriodicalId":9742,"journal":{"name":"Cellular and Molecular Neurobiology","volume":" ","pages":""},"PeriodicalIF":7.4000,"publicationDate":"2026-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13172177/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cellular and Molecular Neurobiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10571-026-01688-9","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Stroke is a major cause of disability and the second greatest cause of death. Both acute and chronic strokes have few available treatment options. Nonetheless, the technique known as genome-wide association study (GWAS) is beginning to significantly influence our comprehension of the genetics of stroke. Therefore, the objective of the present study was to examine the associations between Sirtuin-1 (SIRT1), Methylenetetrahydrofolate reductase (MTHFR), and microRNA 146a (MIR146A) gene variations with ischemic stroke (IS) risk. The study included 200 participants: 100 with clinically confirmed IS and 100 healthy controls. Genotyping of SIRT1 (rs7069102), MTHFR (rs1801131), and MIR146A (rs2910164) was performed using the Amplification-Refractory Mutation System Polymerase Chain Reaction (ARMS-PCR). Blood biochemistry, including lipid profiles and glycemic markers, was determined using spectrophotometric enzymatic colorimetric assays. Statistical techniques employed included the Chi-square test, Fisher’s exact test, and multivariate logistic regression analysis to determine Odds Ratios (OR) and 95% Confidence Intervals (CI). In the codominant model, heterozygosity for MIR146A GC (OR = 1.97, P = 0.040), SIRT1 GC (OR = 1.84, P = 0.044), and MTHFR AC (OR = 2.55, P = 0.0019) was significantly associated with increased stroke susceptibility. In the dominant model, MIR146A (GC + CC), SIRT1 (GC + CC), and MTHFR (AC + CC) genotypes were strongly associated with increased risk (P < 0.05). In the recessive model, MIR146A CC and MTHFR CC genotypes were significantly associated with stroke risk, whereas the SIRT1 CC genotype did not reach statistical significance (P = 0.065). Allelic comparison revealed that the C alleles of MIR146A, SIRT1, and MTHFR were all strongly associated with stroke predisposition (P < 0.05). We conclude that there is a possible strong association between the SIRT1 rs7069102 C > G, MTHFR rs1801131 C > A and MIR146A rs2910164 C > G gene variants and ischemic stroke susceptibility. To the best of our knowledge, it is the first study to highlight the association between these genetic variations and the predisposition of stroke in our populations. Large-scale case–control studies in the future are required to confirm these results. These results, when confirmed, can be used in genetic testing for the screening and prognosis of stroke.
期刊介绍:
Cellular and Molecular Neurobiology publishes original research concerned with the analysis of neuronal and brain function at the cellular and subcellular levels. The journal offers timely, peer-reviewed articles that describe anatomic, genetic, physiologic, pharmacologic, and biochemical approaches to the study of neuronal function and the analysis of elementary mechanisms. Studies are presented on isolated mammalian tissues and intact animals, with investigations aimed at the molecular mechanisms or neuronal responses at the level of single cells. Cellular and Molecular Neurobiology also presents studies of the effects of neurons on other organ systems, such as analysis of the electrical or biochemical response to neurotransmitters or neurohormones on smooth muscle or gland cells.